Paradigm Biopharmaceuticals reported AUD2.36M in Selling and Administration Expenses for its fiscal semester ending in December of 2024.


Selling And Administration Expenses Change Date
Avita Medical AUD 21.23M 2.57M Dec/2024
Medical Developments International AUD 12.94M 5.87M Dec/2024
Neuren Pharmaceuticals AUD 2.33M 47K Dec/2024
Pacific Edge NZD 19.43M 12.04M Sep/2024
PYC Therapeutics AUD 2.58M 1.57M Dec/2024
Telix Pharmaceuticals AUD 55.91M 31.78M Dec/2024